Michalak, M.; Lach, M.S.; Antoszczak, M.; Huczyński, A.; Suchorska, W.M.
Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives—An In Vitro Study. Molecules 2020, 25, 537.
https://doi.org/10.3390/molecules25030537
AMA Style
Michalak M, Lach MS, Antoszczak M, Huczyński A, Suchorska WM.
Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives—An In Vitro Study. Molecules. 2020; 25(3):537.
https://doi.org/10.3390/molecules25030537
Chicago/Turabian Style
Michalak, Marcin, Michał Stefan Lach, Michał Antoszczak, Adam Huczyński, and Wiktoria Maria Suchorska.
2020. "Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives—An In Vitro Study" Molecules 25, no. 3: 537.
https://doi.org/10.3390/molecules25030537
APA Style
Michalak, M., Lach, M. S., Antoszczak, M., Huczyński, A., & Suchorska, W. M.
(2020). Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives—An In Vitro Study. Molecules, 25(3), 537.
https://doi.org/10.3390/molecules25030537